m 6 A RNA Modification Controls HTLV ‐1 Tax and Host Gene Expression
Genes to Cells · 2025
DOI: 10.1111/gtc.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Rei Gibu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The Univer…. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, Gene Products, tax, Adenosine, RNA, Viral. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Human T‐cell Leukemia Virus Type 1 (HTLV‐1) is a pathogenic human retrovirus that is responsible for intractable diseases such as adult T‐cell leukemia–lymphoma (ATL), a malignancy with a poor patient prognosis. Although recent studies have delineated several genomic, epigenomic, and transcriptomic abnormalities associated with HTLV‐1, to date the importance of epitranscriptomic modifications, particularly N 6 ‐methyladenosine (m 6 A), remains unclear. Here, we showed that the HTLV‐1 RNA genome undergoes m 6 A modification, thereby suggesting that these modifications act as bidirectional regulators of both viral and host processes. Moreover, targeted depletion of m 6 A modification within the viral transactivator HTLV‐1 Tax resulted in markedly destabilized Tax mRNA, attenuated Tax protein abundance, and suppression of downstream expression of host genes including IL2RA and TXN . Overall, these findings suggest that m 6 A methylation is an essential determinant of the HTLV‐1 life cycle, and understanding it may offer mechanistic insight into viral latency and present novel avenues for therapeutic intervention and prophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
- Geological Survey of Japan, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan.
- Department of Ecosystem Studies, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
- Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Okinawa, Japan.
- Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Makoto Yamagishi
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Gibu, R., Gibu, K., Suzuki, K., Tanaka, Y., Uchimaru, K., & Yamagishi, M. (2025). m 6 A RNA Modification Controls HTLV ‐1 Tax and Host Gene Expression. Genes to Cells. https://doi.org/10.1111/gtc.70054
Vancouver
Gibu R, Gibu K, Suzuki K, Tanaka Y, Uchimaru K, Yamagishi M. m 6 A RNA Modification Controls HTLV ‐1 Tax and Host Gene Expression. Genes to Cells. 2025. doi:10.1111/gtc.70054
BibTeX
@article{Gibu2025,
author = {Gibu, Rei and Gibu, Kodai and Suzuki, Kako and Tanaka, Yuetsu and Uchimaru, Kaoru and Yamagishi, Makoto},
title = {m 6 A RNA Modification Controls HTLV ‐1 Tax and Host Gene Expression},
journal = {Genes to Cells},
year = {2025},
doi = {10.1111/gtc.70054}
}
EUVIMED